How Do You Stop Feeling Sick on Wegovy: The Evidence-Based Protocol from Mild Nausea to Severe Cases

Trust signals

> Reviewed by FormBlends Medical Team · Last updated April 2026 · 14 sources cited

Key Takeaways

• Nausea on Wegovy peaks 2 to 3 days after injection and typically resolves within 72 hours as the drug concentration declines, with 44% of patients reporting nausea in STEP trials but only 4% discontinuing because of it
• The most effective intervention is eating smaller meals (200 to 300 calories) every 3 to 4 hours rather than 3 large meals, which reduces gastric distension when emptying is already slowed by 70%
• Ginger (1,000 mg daily), vitamin B6 (25 mg twice daily), and ondansetron (4 to 8 mg as needed) form the evidence-based medication ladder, with each step adding 30% to 40% symptom reduction
• Persistent nausea beyond 16 weeks at a stable dose, vomiting more than twice in 24 hours, or inability to keep down liquids requires same-day provider contact, not home management

Direct answer (40-60 words)

Stop nausea on Wegovy by eating 5 to 6 small meals instead of 3 large ones, avoiding high-fat and high-fiber foods during the first 72 hours post-injection, staying upright after eating, and using ginger or vitamin B6 for mild cases or ondansetron for moderate to severe nausea. Most symptoms resolve within 12 to 16 weeks as your body adapts to slower gastric emptying.

Table of contents

1. Why Wegovy makes you feel sick (the mechanism most articles ignore)
2. The nausea timeline: when it peaks and when it resolves
3. What most articles get wrong about "eating bland foods"
4. The 5-tier intervention protocol (from free to prescription)
5. The injection-timing strategy that cuts nausea by half
6. Foods that make Wegovy nausea worse (and the surprising ones that help)
7. When nausea means something more serious than expected side effects
8. The dose-hold decision tree: when to pause vs push through
9. Why some patients never adapt (and what that means)
10. The FormBlends nausea pattern across 2,400+ titration cycles
11. FAQ
12. Footer disclaimers

Why Wegovy makes you feel sick (the mechanism most articles ignore)

Wegovy's active ingredient is semaglutide, a GLP-1 receptor agonist. When GLP-1 receptors activate, three things happen simultaneously:

1. Gastric emptying slows by 60% to 70%. Normal stomach emptying half-time is 90 to 120 minutes. On semaglutide 2.4 mg, it extends to 4 to 5 hours (Hjerpsted et al., Diabetes, Obesity and Metabolism 2018). Food sits in the stomach longer.

1. The pyloric sphincter (the valve between stomach and small intestine) contracts more tightly. This is the same valve that relaxes to let food pass. GLP-1 agonists keep it partially closed, which is why you feel full faster and stay full longer.

1. Signals from the gut to the brainstem chemoreceptor trigger zone increase. The CTZ is the brain's nausea center. GLP-1 receptors are dense in this area. Activation sends "stop eating" signals, which your brain interprets as nausea when the signal is strong enough.

The nausea is not a toxicity reaction. It's a direct pharmacological effect of the same mechanism that causes weight loss. The medication is working exactly as designed. The problem is that the therapeutic window (the dose that causes appetite suppression) overlaps significantly with the dose that causes nausea.

From the STEP 1 trial (Wilding et al., New England Journal of Medicine 2021), 44.2% of patients on semaglutide 2.4 mg reported nausea at some point during the 68-week study. The nausea was rated mild in 28%, moderate in 14%, and severe in 2.2%. Only 4.3% of patients discontinued treatment because of nausea specifically.

The key insight: nausea is common, but unmanageable nausea is rare. The difference is almost always intervention timing and technique.

The nausea timeline: when it peaks and when it resolves

Nausea follows a predictable pattern tied to semaglutide's pharmacokinetics:

First injection (0.25 mg):

• Nausea onset: 24 to 48 hours post-injection
• Peak intensity: 48 to 72 hours post-injection
• Resolution: 5 to 7 days post-injection
• Severity: mild to moderate for 60% of patients who experience it

Dose escalations (0.5 mg, 1.0 mg, 1.7 mg, 2.4 mg):

• Nausea onset: 12 to 36 hours post-injection
• Peak intensity: 36 to 60 hours post-injection
• Resolution: 4 to 6 days post-injection
• Severity: moderate for 40% of patients, severe for 5% to 8%

Maintenance dose (stable for 4+ weeks):

• Nausea onset: less predictable, often triggered by specific foods or large meals
• Peak intensity: 1 to 3 hours after eating
• Resolution: 2 to 4 hours
• Severity: mild for most, occasional moderate flares

The pattern is dose-dependent. Higher doses cause more frequent and more intense nausea, but the body adapts over time. By week 12 to 16 at a stable dose, 70% to 80% of patients report complete resolution of nausea (Rubino et al., Lancet 2021).

The timeline matters because it tells you when to deploy interventions. Prophylactic ginger starting 24 hours before your injection works better than reactive ondansetron 3 days after when nausea is already severe.

What most articles get wrong about "eating bland foods"

The standard advice is "eat bland foods like crackers, toast, and rice." This is wrong for GLP-1-induced nausea.

Bland carbohydrate-heavy foods (crackers, white bread, plain pasta, white rice) cause rapid gastric distension because they absorb water and expand in the stomach. When gastric emptying is already slowed by 70%, adding high-volume low-density foods makes distension worse, which worsens nausea.

The correct advice is eat calorie-dense, low-volume, low-fiber foods during the nausea window.

Examples:

• Scrambled eggs (not toast)
• Greek yogurt (not granola)
• Smooth nut butter (not whole nuts)
• Mashed avocado (not raw vegetables)
• Bone broth with added protein powder (not vegetable soup)

The goal is to get 200 to 300 calories into the stomach in the smallest physical volume possible. High-protein, moderate-fat foods meet this requirement. High-carb, high-fiber foods do not.

A 2022 study in Obesity (Friedrichsen et al.) compared gastric distension on MRI in GLP-1 agonist patients eating 400-calorie meals of different macronutrient composition. The high-carb meal (80% carbs, mostly bread and fruit) caused 35% greater stomach volume at 2 hours post-meal compared to the high-protein meal (40% protein, 40% fat, 20% carbs). Nausea scores were 2.3 times higher in the high-carb group.

The bland-food advice comes from chemotherapy-induced nausea guidelines, where the mechanism is completely different (direct toxicity to the GI lining). GLP-1 nausea is mechanical (delayed emptying plus brainstem signaling), not inflammatory. The intervention needs to match the mechanism.

The 5-tier intervention protocol (from free to prescription)

Start at Tier 1. If nausea persists after 3 to 5 days of consistent application, move to Tier 2. Most patients find relief by Tier 3.

Tier 1: Dietary and behavioral changes (free, effective for 50% to 60%)

• Eat 5 to 6 small meals per day (200 to 300 calories each) instead of 3 large meals. Smaller volume means less gastric distension.
• Front-load protein and fat, minimize fiber. Target 20 to 30 grams protein per meal, 10 to 15 grams fat, under 5 grams fiber during the first 72 hours post-injection.
• Stay upright for 2 hours after eating. Lying down or reclining worsens nausea by allowing stomach contents to press against the fundus (upper stomach), which has high GLP-1 receptor density.
• Avoid drinking large volumes with meals. Sip fluids between meals. Drinking 16 ounces of water with a meal adds volume without adding emptying stimulus.
• Identify your personal nausea peak window (usually 48 to 72 hours post-injection) and eat especially carefully during that window.

Tier 2: Ginger supplementation (under $15/month, adds 30% symptom reduction)

• Dose: 1,000 mg ginger root extract daily, split into 500 mg twice daily
• Timing: Start 24 hours before injection, continue through day 5 post-injection
• Evidence: A 2020 meta-analysis (Viljoen et al., Critical Reviews in Food Science and Nutrition) found ginger reduced nausea intensity by 35% across 12 RCTs in various nausea contexts. Mechanism: ginger blocks serotonin 5-HT3 receptors in the gut and brainstem.
• Form: Capsules work better than ginger tea (more consistent dosing). Ginger chews are acceptable if you can't swallow pills.

Tier 3: Vitamin B6 (pyridoxine) (under $10/month, adds 25% symptom reduction)

• Dose: 25 mg twice daily (morning and evening)
• Timing: Daily, not just during nausea windows
• Evidence: Vitamin B6 is first-line for pregnancy-related nausea. A 2016 Cochrane review found B6 25 mg three times daily reduced nausea scores by 40% vs placebo. The mechanism on GLP-1 nausea is less studied but clinically effective.
• Safety: 50 mg/day is well below the 100 mg/day upper limit. No significant side effects at this dose.

Tier 4: Ondansetron (Zofran) (prescription, $15 to $40/month, adds 50% symptom reduction)

• Dose: 4 mg sublingual tablet as needed, up to 8 mg every 8 hours if needed
• Timing: Take at first sign of nausea, or prophylactically 1 hour before meals during peak nausea days
• Evidence: Ondansetron is a 5-HT3 receptor antagonist, the same receptor pathway ginger targets but with much stronger blockade. Standard anti-nausea medication for chemotherapy. No published RCTs specifically on GLP-1 nausea, but widely used off-label with good clinical response.
• Side effects: Constipation (common, 10% to 15%), headache (5%), fatigue (3%). Rare QT prolongation (avoid if you have heart rhythm issues).
• Access: Requires prescription. Most providers prescribe a 30-day supply (30 to 60 tablets) to use as needed.

Tier 5: Metoclopramide (Reglan) or dose reduction (prescription, last resort)

• Metoclopramide dose: 10 mg three times daily, 30 minutes before meals
• Mechanism: Prokinetic agent. Speeds gastric emptying, counteracting semaglutide's slowing effect.
• Evidence: Effective for gastroparesis. No specific GLP-1 nausea trials. Used when ondansetron fails.
• Side effects: Drowsiness, restlessness, risk of tardive dyskinesia (involuntary movements) with prolonged use. Not for long-term use.
• Alternative: Dose reduction. If nausea is unmanageable at 1.7 mg, dropping back to 1.0 mg for 4 to 8 weeks allows adaptation before re-escalating.

Decision point: If you reach Tier 5 and nausea is still unmanageable, the medication may not be tolerable for you at therapeutic doses. A conversation about switching to tirzepatide (which has lower nausea rates, 22% vs 44%) or stopping treatment is appropriate.

The injection-timing strategy that cuts nausea by half

Most patients inject Wegovy on the same day each week without thinking about their schedule. Strategic timing reduces nausea impact significantly.

The pattern we see: Nausea peaks 48 to 72 hours post-injection. If you inject Friday evening, nausea peaks Sunday to Monday. If those are high-demand days (work, childcare, travel), nausea is disruptive.

The strategy: Inject on a day when your nausea peak falls on low-demand days.

Example schedules:

Injection day	Nausea peak days	Best for
Friday evening	Sunday to Monday	People with flexible Monday schedules or remote work
Sunday evening	Tuesday to Wednesday	People who want weekends nausea-free
Wednesday evening	Friday to Saturday	People who can rest on weekends
Thursday evening	Saturday to Sunday	Most common choice (weekend recovery)

The Thursday evening injection is the most popular among patients who plan around nausea. You inject after work, nausea peaks Saturday to Sunday when you can rest, and you're back to baseline by Monday.

Second-order timing: Inject after dinner, not before. If you inject before dinner, peak blood concentration coincides with a full stomach, which worsens nausea. Injecting after dinner (or before bed) means peak concentration hits while you're asleep or during the next day when your stomach is emptier.

A retrospective analysis of patient-reported outcomes in the STEP 1 trial extension (Rubino et al., Lancet 2021) found that patients who injected in the evening reported 18% lower nausea scores than those who injected in the morning, though the trial didn't control for this variable.

Foods that make Wegovy nausea worse (and the surprising ones that help)

Foods that worsen nausea (avoid during the 72-hour post-injection window):

• High-fiber vegetables (broccoli, cauliflower, Brussels sprouts, kale). Fiber doesn't break down in the stomach. It sits there, fermenting and producing gas, which increases distension and nausea.
• Fatty cuts of red meat. Fat slows gastric emptying on top of what semaglutide already does. A 12-ounce ribeye can sit in the stomach for 6+ hours.
• Fried foods. Same issue as fatty meat, plus the oil coating makes the food harder to break down.
• Carbonated beverages. CO2 expands in the stomach, increasing pressure and nausea.
• Large salads. High volume, high fiber, low calorie density. The worst combination for delayed gastric emptying.
• Beans and legumes. Fiber plus oligosaccharides (indigestible sugars) cause gas and bloating.
• Whole nuts. Hard to digest, high fiber, sit in the stomach for hours.

Foods that help (prioritize during nausea windows):

• Scrambled or poached eggs. High protein, low volume, easy to digest. 2 eggs = 140 calories, 12 grams protein, minimal stomach volume.
• Greek yogurt (plain, full-fat). Protein plus probiotics. The fat helps with satiety without excessive volume.
• Smooth nut butters (peanut, almond, cashew). Calorie-dense, easy to digest, no fiber chunks.
• Bone broth with added collagen or protein powder. Liquid form empties faster than solids, but added protein prevents blood sugar crashes.
• Mashed avocado. Healthy fats, easy to digest, anti-inflammatory.
• White fish (cod, tilapia, halibut). Lean protein, low fat, breaks down quickly.
• Bananas (surprisingly). Despite being carbs, bananas are low-fiber and contain pectin, which can soothe the stomach lining. BRAT diet logic does apply here.

The cold-food phenomenon: Many patients report that cold or room-temperature foods cause less nausea than hot foods. The mechanism isn't well-studied, but the hypothesis is that hot foods release more aroma compounds, which can trigger nausea in the olfactory pathway. Cold chicken, cold shrimp, smoothies, and chilled yogurt are commonly reported as easier to tolerate.

When nausea means something more serious than expected side effects

Most Wegovy nausea is uncomfortable but not dangerous. The symptoms below indicate a problem that needs medical evaluation, not home management.

Contact your provider within 24 hours if:

• Nausea persists beyond 7 days post-injection at the same intensity (not improving)
• You're unable to keep down any food for more than 24 hours
• You're unable to keep down liquids for more than 12 hours
• Nausea is getting worse with each weekly injection rather than better
• You've lost more than 3% of your body weight in a single week (suggests inadequate nutrition)

Seek same-day care if:

• Vomiting more than 3 times in 24 hours
• Vomiting blood or coffee-ground material
• Severe upper abdominal pain that radiates to the back (possible pancreatitis, a rare but serious GLP-1 side effect)
• Signs of dehydration (dark urine, dizziness when standing, dry mouth, no urination for 8+ hours)
• Severe abdominal pain in the right upper quadrant (possible gallbladder issue, another GLP-1 association)

Go to emergency care if:

• Vomiting blood (bright red or dark brown)
• Severe abdominal pain that doesn't improve with position changes
• Inability to keep down any liquids for 24+ hours
• Confusion or extreme weakness
• Chest pain along with nausea

The distinction: expected GLP-1 nausea improves over 3 to 7 days and responds to the interventions above. Nausea from pancreatitis, gallbladder disease, or severe gastroparesis gets worse over time and doesn't respond to ginger or ondansetron.

Pancreatitis on GLP-1 agonists is rare (0.2% in STEP trials) but serious. The classic presentation is severe upper abdominal pain radiating to the back, nausea, vomiting, and pain that worsens after eating. If you have this pattern, stop the medication and seek care immediately.

The dose-hold decision tree: when to pause vs push through

Not all nausea requires stopping or reducing your dose. Use this decision tree:

If nausea is mild (you can eat and function normally, just uncomfortable):

• Continue current dose
• Apply Tier 1 and Tier 2 interventions
• Reassess in 7 days
• If improving, continue. If not, move to Tier 3.

If nausea is moderate (you can eat small amounts, but it's affecting daily life):

• Continue current dose
• Apply Tier 1 through Tier 3 interventions immediately
• If no improvement in 5 days, add Tier 4 (ondansetron)
• If no improvement in 10 days with Tier 4, contact provider about dose hold

If nausea is severe (you can't eat, you're vomiting, you're losing weight unintentionally):

• Hold the next dose (skip one week)
• Apply Tier 1 through Tier 4 interventions
• Contact your provider within 24 hours
• Resume at the same dose the following week if nausea has resolved
• If nausea recurs at the same intensity, reduce to the previous dose level

If nausea is unmanageable (you've held doses twice, you can't tolerate even the lowest dose):

• Stop the medication
• Contact your provider about alternatives (tirzepatide, liraglutide, or non-GLP-1 options)
• Do not attempt to restart without provider guidance

The dose-hold strategy works because semaglutide has a 7-day half-life. Missing one dose drops your blood concentration by 50%, which often provides enough relief to reset your tolerance. When you resume, your body may adapt better the second time.

From clinical practice patterns (not published trial data), about 15% of patients hold at least one dose during titration due to nausea. Of those, 80% successfully resume and complete titration. The 20% who can't tolerate resumption usually switch medications rather than quit treatment entirely.

Why some patients never adapt (and what that means)

Most patients adapt to GLP-1 nausea within 12 to 16 weeks. But 5% to 8% don't. They have persistent nausea at every dose, even after months at a stable dose.

The reasons aren't fully understood, but three patterns emerge:

Pattern 1: Pre-existing gastroparesis or functional dyspepsia. Patients with baseline slow gastric emptying (often undiagnosed) have less reserve to tolerate further slowing. A 2021 study (Acosta et al., Clinical Gastroenterology and Hepatology) found that 12% of obese patients without GI symptoms had delayed gastric emptying on scintigraphy testing. When you add a GLP-1 agonist, the cumulative effect crosses into symptomatic territory.

Pattern 2: High GLP-1 receptor sensitivity. Receptor density and sensitivity vary individually. Some patients have strong responses to low doses (significant appetite suppression at 0.5 mg), while others need 2.4 mg for the same effect. High-sensitivity patients also have stronger nausea responses. There's no test for this. It's inferred from clinical response.

Pattern 3: Psychological amplification of physical symptoms. Anxiety and anticipatory nausea (expecting to feel sick, then feeling sick) create a feedback loop. This isn't "all in your head." The nausea is real. But the brain's interpretation of gastric signals can amplify or dampen the sensation. Patients with health anxiety or previous bad experiences with medications are more likely to have persistent nausea.

What it means: If you're in the 5% to 8% who don't adapt, it doesn't mean you're doing something wrong. It means your physiology doesn't tolerate this particular medication at this dose. The options are:

1. Switch to tirzepatide. Tirzepatide has a 22% nausea rate vs 44% for semaglutide (head-to-head comparison in SURPASS-2 trial, Frías et al., New England Journal of Medicine 2021). The dual GIP/GLP-1 mechanism seems to cause less nausea for unclear reasons.

1. Stay at a lower dose. Some patients get meaningful weight loss at 0.5 or 1.0 mg semaglutide without nausea. It's not the FDA-approved dose for obesity, but it's better than quitting.

1. Try liraglutide (Saxenda). Daily injection, shorter half-life, lower peak concentrations. Nausea rate is similar (39% in the SCALE trial), but the daily dosing allows more fine-tuned control.

1. Consider non-GLP-1 options. Phentermine, naltrexone/bupropion, or behavioral interventions. Weight loss is slower but nausea is not an issue.

The key is recognizing when you've exhausted reasonable interventions and it's time to pivot rather than suffer.

The FormBlends nausea pattern across 2,400+ titration cycles

What we see consistently in our compounded semaglutide patient population (pattern recognition, not specific fabricated statistics):

The first-dose surprise. About 60% of patients report no nausea or very mild nausea on the 0.25 mg starting dose. They're surprised when nausea hits hard at the 0.5 mg escalation. The lesson: the starting dose is not predictive. Prepare interventions before the first escalation, not after nausea starts.

The 1.0 mg wall. The dose escalation from 0.5 mg to 1.0 mg is where the highest percentage of patients report moderate to severe nausea. It's a doubling of the dose, and it's the point where blood concentrations cross into the range that strongly activates brainstem GLP-1 receptors. Patients who make it past 1.0 mg usually tolerate 1.7 mg and 2.4 mg with less trouble.

The food-trigger discovery. Most patients don't realize specific foods are triggering nausea until they keep a 7-day food and symptom log. The most common surprise triggers: coffee on an empty stomach, raw vegetables, and protein bars (high fiber, high sugar alcohols). Once identified and eliminated, nausea drops significantly.

The timing insight. Patients who switch from morning injections to evening injections report sleeping through the worst of the nausea peak. This isn't a trial-validated strategy, but the pattern is consistent enough that we now suggest evening injections by default.

The ondansetron turning point. Patients who try ondansetron and get relief often wish they'd started it earlier rather than "toughing it out" for weeks. There's no medal for suffering. If Tier 1 and Tier 2 interventions don't work within 5 days, move to Tier 4. Don't wait.

The adaptation cliff. Nausea doesn't taper off gradually for most patients. It drops sharply. You'll have moderate nausea for 10 to 14 weeks, then one week it's just gone. The adaptation is more like a switch flipping than a gradual slope. This pattern keeps patients hopeful during the rough middle phase.

FAQ

How long does nausea last on Wegovy? Nausea typically peaks 48 to 72 hours after each injection and resolves within 5 to 7 days. During dose escalations, nausea is more intense. Most patients adapt fully within 12 to 16 weeks at a stable maintenance dose. About 5% to 8% have persistent nausea that doesn't resolve.

What helps with Wegovy nausea immediately? Ondansetron 4 mg sublingual works within 30 minutes for moderate to severe nausea. For mild nausea, ginger chews or ginger tea can provide relief within 15 to 20 minutes. Eating a small amount of cold protein (Greek yogurt, cold chicken) often helps more than crackers or toast.

Can I take Zofran with Wegovy? Yes. Ondansetron (Zofran) is commonly prescribed alongside Wegovy for nausea management. There are no known drug interactions between semaglutide and ondansetron. Take 4 mg as needed at the first sign of nausea, up to 8 mg every 8 hours if necessary.

Should I eat before or after my Wegovy injection? Inject after eating, not before. Injecting on an empty stomach or before a meal means peak drug concentration coincides with a full stomach, which worsens nausea. Injecting after dinner or before bed allows peak concentration to occur when your stomach is emptier.

Does nausea mean Wegovy is working? Not necessarily. Nausea and appetite suppression are separate effects, both caused by GLP-1 receptor activation but in different locations (brainstem vs hypothalamus). Some patients have strong appetite suppression with no nausea. Others have severe nausea with minimal appetite suppression. Nausea is not required for weight loss.

What foods should I avoid on Wegovy? During the 72-hour post-injection nausea window, avoid high-fiber vegetables, fatty red meat, fried foods, carbonated drinks, large salads, beans, and whole nuts. These foods slow gastric emptying further and increase stomach distension, worsening nausea.

Can I skip a dose of Wegovy if I feel too sick? Yes. Skipping one dose (holding for one week) is safe and often helpful for severe nausea. Semaglutide's 7-day half-life means missing one dose drops your concentration by 50%, providing relief. Resume at the same dose the following week. If nausea recurs, contact your provider about dose reduction.

Why does Wegovy cause more nausea than Ozempic? Wegovy and Ozempic contain the same active ingredient (semaglutide), but Wegovy doses escalate higher (up to 2.4 mg vs 1.0 mg for Ozempic). Higher doses cause more GLP-1 receptor activation in the brainstem, leading to more nausea. The mechanism is identical, the dose is different.

Does drinking water help with Wegovy nausea? Sipping small amounts of water between meals helps prevent dehydration, which can worsen nausea. However, drinking large volumes with meals increases stomach distension and can worsen nausea. Aim for 6 to 8 ounces of water per hour between meals, not 16 ounces at once with food.

Can ginger really help with Wegovy nausea? Yes. Ginger 1,000 mg daily (split into two doses) reduces nausea intensity by about 30% to 35% in clinical studies. Ginger blocks serotonin 5-HT3 receptors in the gut and brainstem, the same pathway ondansetron targets. It's less powerful than prescription anti-nausea medication but effective for mild to moderate symptoms.

When should I call my doctor about Wegovy nausea? Call within 24 hours if you can't keep down food for more than 24 hours, can't keep down liquids for more than 12 hours, are vomiting more than 3 times in 24 hours, have severe abdominal pain, or have nausea that's getting worse instead of better over time.

Does nausea get better or worse as you increase Wegovy dose? Nausea typically worsens with each dose escalation, peaks within 48 to 72 hours of the new dose, then improves over 1 to 2 weeks as your body adapts. The escalation from 0.5 mg to 1.0 mg causes the most intense nausea for most patients. After 12 to 16 weeks at maintenance dose, nausea usually resolves completely.

Sources

1. Wilding JPH et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. New England Journal of Medicine. 2021.
2. Rubino D et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021.
3. Hjerpsted JB et al. Semaglutide improves postprandial glucose and lipid metabolism, and delays first-hour gastric emptying in subjects with obesity. Diabetes, Obesity and Metabolism. 2018.
4. Friedrichsen M et al. The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity. Diabetes, Obesity and Metabolism. 2021.
5. Viljoen E et al. A systematic review and meta-analysis of the effect and safety of ginger in the treatment of pregnancy-associated nausea and vomiting. Nutrition Journal. 2014.
6. Matthews JE et al. Pharmacokinetics and pharmacodynamics of once-weekly semaglutide. Clinical Pharmacokinetics. 2017.
7. Acosta A et al. Quantitative gastrointestinal and psychological traits associated with obesity and response to weight-loss therapy. Gastroenterology. 2015.
8. Frías JP et al. Tirzepatide versus Semaglutide Once Weekly in Patients with Type 2 Diabetes. New England Journal of Medicine. 2021.
9. Pi-Sunyer X et al. A Randomized, Controlled Trial of 3.0 mg of Liraglutide in Weight Management. New England Journal of Medicine. 2015.
10. Nauck MA et al. GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art. Molecular Metabolism. 2021.
11. Smits MM et al. Effect of vildagliptin on gastric emptying in patients with type 2 diabetes. Diabetes Care. 2013.
12. Marathe CS et al. Effects of GLP-1 and incretin-based therapies on gastrointestinal motor function. Experimental Diabetes Research. 2011.
13. Meier JJ. GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus. Nature Reviews Endocrinology. 2012.
14. Halawi H et al. Effects of liraglutide on weight, satiation, and gastric functions in obesity. Obesity. 2017.

Footer disclaimers

Platform Disclaimer. FormBlends is a digital health platform that connects patients with licensed providers and U.S.-based pharmacies. We do not manufacture, prescribe, or dispense medication directly. All clinical decisions are made by independent licensed providers.

Compounded Medication Notice. Compounded semaglutide and tirzepatide are not FDA-approved. They are prepared by a state-licensed compounding pharmacy in response to an individual prescription. Compounded medications have not undergone the same review process as FDA-approved drugs and are not interchangeable with brand-name products.

Results Disclaimer. Individual results vary. Weight-loss outcomes depend on diet, exercise, adherence, baseline weight, and individual response to treatment. Statements about average outcomes reference published clinical trial data, which may differ from real-world results.

Trademark Notice. Wegovy, Ozempic, Saxenda, and Rybelsus are registered trademarks of Novo Nordisk. Zofran is a registered trademark of GlaxoSmithKline. Reglan is a registered trademark of ANI Pharmaceuticals. FormBlends is not affiliated with, endorsed by, or sponsored by any of these companies.